Integral Board-Level Human-Capital Risk Advisory

Last updated: May 2026

Human-capital risk has become Board-level fiduciary territory. Silent attrition, moral injury exposure, leadership succession gaps, and AI-deployment workforce failures are no longer CHRO-level operational concerns — they carry fiduciary, regulatory, and reputational consequences that Boards are now expected to govern. Few advisors speak both the human-capital language and the Board governance language. This retainer closes that gap.

What This Advisory Is

The Integral Board-Level Human-Capital Risk Advisory is a quarterly retainer that gives healthcare Boards an analytically grounded view of human-capital risk as a primary organizational risk — covering workforce attrition, executive cohesion, post-incident readiness, M&A integration, AI workforce governance, and the meaning-erosion drivers of physician and clinical-staff attrition. Principal-delivered by Thomas G. Goddard, JD, PhD, CCEP, directly to Board members on the Board's own governance calendar. It is not a management consulting engagement delivered to the C-suite. It is not an engagement-survey report forwarded up the chain. It is principal-to-Board advisory that equips the Board to exercise its fiduciary oversight responsibility over the human layer of organizational performance.

The advisory operates across all four dimensions of human-capital risk: the physiological sustainability of the workforce under load (body); the emotional coherence of leadership and clinical teams and their capacity to hold meaning in the work (heart); the structural, cognitive, and AI-governance risks embedded in how the organization is designed and how decisions are made (mind); and the vocation and moral source of senior leaders and the workforce — the dimension most directly implicated in CEO succession, post-incident recovery, and the long-term retention of the people the organization cannot afford to lose (meaning and purpose).

What the Advisory Addresses

  • Workforce sustainability risk — the attrition, silent disengagement, and moral injury exposure patterns that produce fiduciary risk when they go ungoverned. Boards that learn about workforce-sustainability failures from a regulatory finding or a class-action complaint have been governing retrospectively. The advisory gives the Board a prospective view.
  • Leadership succession readiness — the depth, health, and readiness of the leadership pipeline, including the CEO succession question and the identification of successor-cohort development gaps before they become crisis decisions.
  • Moral injury exposure — the systematic pattern in which healthcare workers are structurally prevented from delivering the care or service they were trained to deliver. In utilization management, prior authorization, and denial-cascade functions, moral injury is measurable and produces fiduciary risk. It is not an individual-wellness problem; it is a governance problem.
  • AI-deployment workforce governance — as AI deployment in healthcare moves from CIO-level to Board-level responsibility, the workforce implications of AI decisions (displacement, retraining, quality-of-work degradation, liability exposure from AI-assisted clinical decisions) require Board visibility. The advisory frames AI workforce risk in the governance vocabulary Boards already use for technology risk and fiduciary duty.
  • Post-incident readiness — the Board's fiduciary obligation includes preparedness for the human-capital dimension of post-incident response: staff psychological safety, leadership cohesion, public narrative, and organizational recovery. The advisory builds Board fluency in post-incident human-capital governance before the incident occurs.

What This Advisory Does Not Claim

The advisory does not supervise the CHRO function or override operational workforce management. It does not promise clinical outcomes, patient-safety metrics, or litigation avoidance. It does not produce a workforce diagnostic — that is the Integral Organizational Nervous-System Diagnostic, a separate engagement. It is a governance advisory: it equips the Board to ask the right questions, see the right data, and exercise informed fiduciary judgment over human-capital risk.

The Governance Anchors

The advisory is grounded in the governance frameworks Board members already work within, supplemented by the workforce-risk research that makes those frameworks substantive rather than procedural.

NACD human-capital governance guidance — The National Association of Corporate Directors has increasingly framed human-capital management as a Board-level governance responsibility, not a management function delegated to the CHRO. NACD's guidance on human-capital risk disclosure and the Board's role in workforce sustainability provides the governance architecture the advisory works within.

Delaware corporate-law fiduciary-duty framework — Delaware courts have consistently extended the Caremark duty-of-oversight doctrine to require that Boards exercise substantive oversight over risks that are both material and identified. Human-capital risk — particularly in healthcare, where workforce failures produce regulatory exposure, patient-safety risk, and reputational harm — meets both criteria. The advisory gives Boards the documented oversight process that Caremark compliance requires.

SIOP and I/O psychology research on workforce risk — The Society for Industrial and Organizational Psychology evidence base provides the measurement instruments and validated constructs behind the advisory's workforce-risk framing: Trockel et al.'s finding that organizational factors account for approximately 70% of physician burnout variance (JAMA Internal Medicine, 2018); West et al.'s finding that organizational interventions outperform individual ones on burnout outcomes (The Lancet, 2016); and the broader literature on leadership succession, organizational climate, and the structural drivers of voluntary attrition.

Moral injury as fiduciary risk — Moral injury research (Litz et al.; Dean et al., BMJ, 2019) documents the pattern in which individuals are prevented from acting in accordance with their moral framework by the structures they work within. In healthcare, this pattern concentrates in utilization-management, prior-authorization, and denial-cascade functions. When it is not governed, it produces attrition, regulatory exposure, and — in the Wit v. United Behavioral Health litigation — federal court findings about the organizational systems that produced it. Boards that govern this risk prospectively are in a materially different position than Boards that encounter it in litigation.

AHA and AHLA Board-governance literature — The American Hospital Association and American Health Law Association Board-governance resources frame workforce sustainability as a Board-level strategic risk in healthcare-specific terms, calibrated to the regulatory, payer, and workforce-supply conditions of U.S. healthcare in 2026.

Who Needs This Advisory

The advisory is calibrated to healthcare Boards where human-capital risk has crossed from operational concern to governance concern. Board Chair, Audit Committee Chair, Compensation Committee Chair, and Governance Committee Chair are the primary principals; CEO is the secondary principal where the CEO serves as the Board's primary interface on workforce matters.

Board-level human-capital risk is no longer abstract. NSI 2026 reports US hospital turnover at 18.5% with RN turnover at 17.6%; about 1.08 million hospital workers exited in the most recent reporting cycle. 55% of US healthcare workers report considering leaving within twelve months (National Council on Behavioral Health). 82% of US physicians are employed by hospitals, PE, insurers, or corporate entities (Avalere/PAI); PE represents over 90% of physician-practice M&A (FOCUS Bankers). Verdicts above $10M have more than doubled since 2015 — average $40M (Insurance Journal). The Change Healthcare 2024 attack compromised 193 million individuals' data (ITIF). Each of these is now a board-fiduciary question, not an HR question. The advisory equips the Board to govern the human layer at the same standard of analytical rigor it applies to financial and strategic risk.

  • Health plan Boards — utilization-management workforce sustainability, AI-enabled prior-authorization governance, CMS scrutiny of UM staffing and decision-quality, and the moral injury exposure of staff operating under denial-cascade workflows are all Board-level risks in 2026. CMS-0057-F implementation has elevated workforce governance from a CHRO concern to a Board concern.
  • PBM Boards — clinical pharmacist workforce sustainability, AI-deployment governance in formulary and step-therapy decision tools, and the downstream regulatory exposure from workforce failures in high-volume authorization functions are increasingly surfacing at the Board level.
  • Specialty pharmacy Boards — reimbursement adversity (copay-accumulator, manufacturer-assistance unwinding, payer-mix compression) concentrates retention risk on the senior clinical staff most critical to program-integrity functions. Board visibility into this risk is fiduciary, not aspirational.
  • MBHO and managed care Boards — utilization-review staff, intake clinicians, and authorization staff in a sector with documented workforce-supply collapse. The Wit litigation has made Board-level governance of UM workforce conditions a legally relevant question, not just a management concern.
  • Hospital system and health system Boards — clinical-leadership succession, charge-nurse and department-chair pipeline depth, and post-merger or post-incident workforce recovery are recurring Board-level agenda items that deserve structured advisory support rather than episodic management briefings.
  • PE-portfolio Boards and Investment Committees — human-capital risk in PE-portfolio healthcare platforms is a direct driver of exit-multiple outcomes. The advisory gives PE Boards visibility into workforce sustainability, leadership-team health, and AI-deployment workforce risk at the cadence that portfolio governance requires.
  • Large physician group Boards and FQHC Boards — where the workforce sustainability question has become a governance concern and where leadership succession is a material risk to organizational continuity.

The Quarterly Advisory Structure

The advisory is built around the Board's existing calendar. It does not ask the Board to create new governance infrastructure; it equips the Board to exercise better judgment inside the infrastructure it already has.

Quarterly Board-Level Human-Capital Risk Briefing

Before each regular Board meeting, the principal delivers a structured briefing to the relevant Board committee covering: voluntary attrition rate trends and leading-indicator patterns; moral injury exposure signals in the workforce functions carrying the highest load; leadership-team health and succession-depth indicators; AI-deployment workforce-impact developments since the prior quarter; and post-incident readiness status. The briefing is calibrated to Board decision-making, not operational management. It names risks, quantifies where quantification is possible, and surfaces the questions the Board should be asking the C-suite.

Annual Board Retreat Session on Human-Capital Strategy

A half-day working session at the annual Board retreat that integrates the year's quarterly briefing data into a strategic view of the organization's human-capital risk posture, succession readiness, and governance gaps. The session is working, not presentational — it is designed to produce Board decisions, not Board awareness.

On-Demand Advisory for Board-Level Human-Capital Decisions

Available within the retainer for specific Board decisions with a material human-capital component: M&A people due diligence; CEO succession (assessment of internal candidates, external search parameters, and the human-capital transition plan); AI governance votes (workforce implications of proposed AI deployments); major restructuring decisions; and post-incident Board response (the fiduciary and workforce dimensions of organizational recovery).

Direct C-Suite Engagement at Board Request

At the Board's direction, the principal engages directly with senior executives on human-capital risk matters the Board has identified — not as a management consultant to the C-suite, but as the Board's advisory resource in a specific conversation. This preserves the advisory's Board-governance posture while allowing the Board to use it as a bridge to the management layer when that is useful.

Compensation Committee Advisory on Executive Incentive Design

Executive incentive structures can inadvertently reward behaviors that worsen workforce sustainability, moral injury exposure, and leadership-team health. The Compensation Committee workstream advises on how incentive design interacts with those outcomes, drawing on I/O psychology research on performance management, intrinsic motivation, and the relationship between executive reward structures and organizational culture.

What the Board Receives

  • Quarterly Human-Capital Risk Briefing document — a structured written briefing calibrated to Board committee use, covering the five risk domains (workforce sustainability, moral injury exposure, leadership-team health, AI-deployment workforce impact, post-incident readiness) with trend indicators, governance questions for the C-suite, and recommended Board actions where warranted.
  • Annual Human-Capital Strategy Session — a half-day facilitated working session at the Board retreat, integrating the year's data into strategic decisions on governance priorities, succession investments, and risk-mitigation commitments.
  • On-demand advisory access — principal availability for specific Board decisions within the retainer scope, with response within 48 hours for non-emergency requests and same-day for urgent matters (post-incident, CEO departure, regulatory action).
  • Documented governance process — the quarterly briefings and annual session materials constitute the Board's documented human-capital governance record — substantive evidence of the oversight process that Delaware corporate law, NACD guidance, and SEC human-capital disclosure expectations increasingly require.
  • Compensation Committee workstream — available as a standalone add-on or as a full workstream within the retainer, depending on the Committee's needs and the Board's charter allocation of human-capital governance responsibility.

Why This Differs

From Standard Board Governance Consulting

Standard governance consultants — Spencer Stuart, Russell Reynolds, Korn Ferry at the Board level — advise on Board composition, director recruitment, governance structure, and CEO succession process. They do not measure workforce sustainability, do not surface moral injury exposure, and do not frame AI-deployment workforce risk in governance terms. Their vocabulary is governance architecture; the Integral advisory adds the human-capital risk content that governance architecture alone does not see.

From Executive Search Firm Board Advisory

Executive search firms provide CEO succession support as a transaction: identify and evaluate candidates, manage the search process, close the placement. They do not maintain ongoing visibility into the human-capital risks that make succession necessary, do not surface the leadership-pipeline gaps that make succession urgent, and do not provide the between-succession advisory that makes succession less crisis-driven. The Integral advisory is a continuous governance relationship, not a transactional search service.

From CHRO-Level Workforce Consulting

The workforce consulting firms that advise the CHRO function — Mercer, Aon, Willis Towers Watson, Korn Ferry at the HR level — operate in the management layer. They produce compensation benchmarks, benefits design, and engagement survey reports for management use. They are not structured to provide independent Board-level visibility into human-capital risk, and they do not speak the governance-and-fiduciary vocabulary Boards use. The Integral advisory operates at the governance layer and speaks both languages.

Why IHS for This Advisory

Board advisory work requires a credential set that most healthcare consultants do not assemble in one person. The principal brings the rare combination that makes this advisory structurally different from what governance consultants, search firms, and HR consulting firms can offer.

About the Principal

Thomas G. Goddard, JD, PhD, CCEP — CEO of Integral Healthcare Solutions; Founding Member of the Integral Institute of Medicine.

Juris Doctor and fiduciary-duty fluency. The advisory's governance anchors — Delaware Caremark doctrine, NACD human-capital disclosure guidance, healthcare-specific Board-governance literature — require legal and fiduciary-duty literacy. Tom holds a JD from the University of Arizona and served as COO and General Counsel of URAC, as VP and General Counsel of NYLCare Health Plans of the Mid-Atlantic (500,000 members), and as Counsel for Government and Media Relations at the National Association of Insurance Commissioners. He has operated at the intersection of healthcare regulation and Board-level governance for four decades.

PhD in Industrial-Organizational Psychology. The workforce-risk measurement behind the advisory — validated survey instruments, burnout constructs, attrition-risk modeling, leadership-succession assessment frameworks — requires I/O psychology depth. Tom holds a PhD in I/O Psychology from George Mason University, the measurement and validation discipline that underpins every substantive claim the advisory makes about workforce risk.

Twenty-five years as IHS CEO and four decades across U.S. healthcare. Special Assistant to a U.S. governor on Medicaid policy; COO and General Counsel of URAC; VP and General Counsel of a 500,000-member health plan; Senior Consultant at Booz Allen Hamilton; twenty-four years as CEO of Integral Healthcare Solutions. Faculty appointments at George Mason University School of Management and Seton Hall Law School's Healthcare Compliance Certification Program.

Certified Core Energetics Practitioner (CCEP). The heart and meaning-and-purpose dimensions of the advisory — moral source, vocation, the meaning-and-purpose dimension of CEO succession and post-incident recovery — require a practitioner credential in somatic and embodied work. Tom is one of the few CCEP-credentialed consultants in U.S. healthcare. This credential makes the advisory's coverage of vocation and purpose coherent rather than rhetorical.

Expert witness experience that translates to Board credibility. Tom served as expert witness in Wit v. United Behavioral Health and seven other federal and state cases. Boards facing fiduciary-duty scrutiny on human-capital governance matters benefit from an advisor who has testified on these questions in federal court — the vocabulary of expert witness work is the vocabulary of Board fiduciary accountability.

Frequently Asked Questions

How does the Board-level advisory relate to the organization's existing CHRO function?

The advisory is not a substitute for the CHRO function and does not supervise the CHRO. It operates at the governance layer — equipping the Board to exercise its fiduciary oversight responsibility over human-capital risk, the same way the Audit Committee engages external auditors to supplement, not replace, internal finance. The CHRO continues to own operational workforce management. The advisory gives the Board independent, analytically grounded visibility into the human-capital risks the organization carries.

What is the time commitment for Board members?

The core commitment is a quarterly 90-minute session aligned with the existing Board calendar. The annual Board retreat session is a half-day. On-demand advisory for specific decisions is scoped at the time the request arises. Total Board time across a full year is typically 8-12 hours.

Does this advisory apply to non-profit Boards and PE Boards as well as public-company Boards?

Yes. Non-profit healthcare Boards carry fiduciary duties under state law and IRS governance standards that include human-capital stewardship. PE Boards and Investment Committees carry human-capital governance responsibility over portfolio companies, and human-capital risk is a direct driver of exit-multiple outcomes. The advisory is calibrated to the governance structure and vocabulary of each Board type.

How is the advisory relationship kept confidential?

The advisory relationship is covered by a mutual confidentiality agreement executed before the engagement begins. Board-level briefing materials are produced for Board use only and are not shared with management unless the Board directs otherwise. Individual interviews and data collected from senior leaders are reported in aggregate or thematic form to the Board — never individually attributed without the interviewee's explicit consent.

Can the Compensation Committee engage IHS specifically for executive incentive advisory work?

Yes — either as a standalone engagement or as a workstream within the broader retainer. IHS advises Compensation Committees on how incentive design interacts with workforce sustainability, moral injury exposure, and leadership-team health, drawing on I/O psychology research on performance management, intrinsic motivation, and the behavioral economics of executive compensation.

How is the value of the advisory measured?

Most precisely, against the fiduciary risk the Board is equipped to see and govern before it materializes. Operationally, the Board will have documented evidence of its human-capital governance process — risk briefings, decision records, annual retreat materials — which matters in the context of Delaware corporate law, NACD governance expectations, and human-capital disclosure scrutiny. Workforce sustainability metrics tracked across the advisory period provide a lagging indicator of the advisory's effect on organizational outcomes.

What happens after the initial 12-24 month commitment?

After the initial period, the Board has a documented human-capital governance process, a baseline against which subsequent data is measured, and leadership fluency in framing workforce risk in governance terms. Continuation decisions are made by the Board at the end of the initial term. Many Boards continue; some transition to a lighter annual cadence. The advisory does not assume indefinite engagement.

What credential qualifies IHS to advise at the Board level?

Thomas G. Goddard, JD, PhD, CCEP brings the combination that Board-level human-capital advisory requires: a JD with deep experience in Delaware fiduciary-duty frameworks and healthcare regulatory exposure at the Board level; a PhD in I/O Psychology calibrated to the measurement and governance of workforce risk; 25 years as CEO of Integral Healthcare Solutions across health plan, PBM, specialty pharmacy, MBHO, MCO, and hospital system clients; prior service as COO and General Counsel of URAC; and expert witness testimony in Wit v. United Behavioral Health and seven other federal and state cases.

Related Resources

Discuss the Advisory with IHS

Board advisory engagements begin with a confidential conversation about the human-capital risks your Board is currently governing — or not yet governing. Retainer pricing is scoped per engagement. Contact us for a proposal.

Schedule a Confidential Consultation